PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Same cell death pathway involved in three forms of blindness, Penn team finds

2014-01-17
(Press-News.org) Contact information: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania
Same cell death pathway involved in three forms of blindness, Penn team finds

Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While effective, the downside to these approaches to vision rescue is that each disease requires its own form of gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.

Hoping to develop a treatment that works more broadly across diseases, a Penn Vet team used canine disease models to closely examine how retinal gene activity varied during the progression of three different forms of inherited vision disease. Their results turned up an unexpected commonality: Early on in each of the diseases, genes involved in the same specific pathway of cell death appeared to be activated. These findings point to possible interventions that could curb vision loss across a variety of inherited retinal diseases.

The work, published in PLOS ONE, was conducted by Sem Genini, a senior research investigator; William A. Beltran, assistant professor of ophthalmology; and Gustavo D. Aguirre, professor of medical genetics and ophthalmology, all of Penn Vet's Department of Clinical Studies, Philadelphia.

The team examined three forms of retinal degenerative diseases, rod cone dysplasia 1 being the most severe, or earliest onset, followed by X-linked progressive retinal atrophy 2 and then early retinal degeneration. All of these diseases involve the death of photoreceptor cells and each is caused by a distinct genetic mutation. But what scientists did not know is how the mutations trigger a molecular signaling pathway that leads to the death of photoreceptor cells.

"What we have in mind is to be able to address multiple forms of disease with one treatment," Beltran said. "We wanted to get a better understanding of whether there are any common cell death or cell survival pathways that could be targeted in some of these diseases."

The researchers looked at the activity of 112 genes in diseased retinas and compared it to gene activity in normal retinas. They assessed gene activity at time points known to correspond with key phases of disease: the "induction phase," the time before the peak level of photoreceptor cell death; the "execution phase," when the highest rates of photoreceptor cell death occur; and the "chronic phase," during which photoreceptor cell death continues at somewhat reduced levels.

During the execution and chronic phases of disease, the researchers identified a number of genes involved in programmed cell death, or apoptosis, that had noticeably different patterns of expression between the diseased and normal dogs.

Of note, several proteins involved in the tumor necrosis factor, or TNF, pathway increased in activity during the induction and execution phases. This pathway is implicated in many diseases, from diabetes to cancer to rheumatoid arthritis.

"This is quite a new result," Genini said. "It was not expected to have the TNF pathway upregulated."

"We assumed," Aguirre said, "the diseases would be different from one another and that cells would commit suicide by their own specific pathway and that perhaps quite late they would have a common final pathway. But what this shows is that there is an early trigger that is quite similar among all three diseases."

An additional surprise was that the differentially expressed proteins were present not only in photoreceptor cells but also in other cells in the retina, including horizontal and Müller cells.

"We were focusing on what would happen with the photoreceptor cells, the cells that we knew were dying," Beltran said. "But what our results are telling us is that, sure, they are dying, but there is something else happening with the cells that they talk to."

Pharmaceutical companies have already developed TNF-inhibitors to treat diseases like rheumatoid arthritis. Genini, Beltran and Aguirre say their results suggest that these drugs or similar ones might have a role to play in the retinal diseases they investigated and perhaps in others that their team is currently studying.

"On its own," Beltran said, "a TNF-inhibitor might not be a cure, but it could be used complementary to gene therapy, either by slowing the course of degeneration before the corrective gene therapy is delivered or in combination with the corrective gene therapy."



INFORMATION:



The research was supported by the Foundation Fighting Blindness, the National Institutes of Health, the Van Sloun Fund for Canine Genetic Research, Hope for Vision and the Macula Vision Research Foundation.



ELSE PRESS RELEASES FROM THIS DATE:

National Park Service and outside experts collaborate to conserve migratory wildlife

2014-01-17
National Park Service and outside experts collaborate to conserve migratory wildlife A new paper details a collaboration between the National Park Service (NPS) and outside experts, including Wildlife Conservation Society (WCS) scientists, in developing recommendations ...

Prion discovery could help keep deadly brain diseases in check

2014-01-17
Prion discovery could help keep deadly brain diseases in check New research from David Westaway, PhD, of the University of Alberta and Jiri Safar, PhD, Case Western Reserve University School of Medicine has uncovered a quality control mechanism in brain cells ...

Loyola researchers identify risk factor for life-threatening disease in preemies

2014-01-17
Loyola researchers identify risk factor for life-threatening disease in preemies Many premature infants suffer a life-threatening bowel infection called necrotizing enterocolitis (NEC). Researchers at Loyola University Health System have identified a marker ...

Parietal gray matter volume changes may be associated with early PD memory deficits

2014-01-17
Parietal gray matter volume changes may be associated with early PD memory deficits New findings published in the Journal of Parkinson's Disease Amsterdam, NL, 16 January 2014 – Research by a team of investigators in Finland suggests that the free recall memory deficits common ...

Penn Museum team finds evidence for 3,000+-year-old 'Nordic grog' tradition

2014-01-17
Penn Museum team finds evidence for 3,000+-year-old 'Nordic grog' tradition Discovery highlights innovative and complex fermented beverages of northernmost Europe in the Bronze and Iron Ages From northwest Denmark, circa 1500-1300 BC, to the Swedish island of Gotland ...

Higher vitamin D levels associated with better cognition and mood in PD patients

2014-01-17
Higher vitamin D levels associated with better cognition and mood in PD patients Findings published in the Journal of Parkinson's Disease Amsterdam, NL, 16 January 2014 – A new study exploring vitamin D levels in patients with Parkinson's disease (PD) opens up the possibility ...

Sarcophagus leads Penn Museum team in Egypt to the tomb of a previously unknown pharaoh

2014-01-17
Sarcophagus leads Penn Museum team in Egypt to the tomb of a previously unknown pharaoh Discovery provides evidence of a forgotten Egyptian dynasty from 3,600 years ago Archaeologists working at the southern Egyptian site of Abydos have discovered the tomb of a previously ...

Big-headed fossil flies track major ecological revolution

2014-01-17
Big-headed fossil flies track major ecological revolution Simon Fraser University's Bruce Archibald and Rolf Mathewes are part of a team of biologists, including Christian Kehlmaier from Germany's Senkenberg Natural History Collections, that has discovered three new, ...

Statin use reduces delirium in critically ill patients

2014-01-17
Statin use reduces delirium in critically ill patients Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission, according to a new study of 470 intensive care patients in the UK. "This is the first ...

Vitamin D supplements reduce pain in fibromyalgia sufferers

2014-01-17
Vitamin D supplements reduce pain in fibromyalgia sufferers Researchers say Vitamin D may be cost-effective treatment or adjunct for patients with fibromyalgia syndrome and low vitamin D levels, reports PAIN® Philadelphia, January 17, 2014 – Patients with fibromyalgia ...

LAST 30 PRESS RELEASES:

Scripps Research scientists unlock new patterns of protein behavior in cell membranes

Panama Canal may face frequent extreme water lows in coming decades

Flash Joule heating lights up lithium extraction from ores

COMBINEDBrain and MUSC announce partnership to establish biorepository for pediatric cerebrospinal fluid and CNS tissue bank

Questionable lead reporting for drinking water virtually vanished after Flint water crisis, study reveals

Assessing overconfidence among national security officials

Bridging two frontiers: Mitochondria & microbiota, Targeting Extracellular Vesicles 2025 to explore game-changing pathways in medicine

New imaging tech promises to help doctors better diagnose and treat skin cancers

Once dominant, US agricultural exports falter amid trade disputes and rising competition

Biochar from invasive weed shields rice from toxic nanoplastics and heavy metals

Rice University announces second cohort of Chevron Energy Graduate Fellows

Soil bacteria and minerals form a natural “battery” that breaks down antibiotics in the dark

Jamestown colonists brought donkeys, not just horses, to North America, old bones reveal

FIU cybersecurity researchers develop midflight defense against drone hijacking

Kennesaw State researcher aims to discover how ideas spread in the digital age

Next-generation perovskite solar cells are closer to commercial use

Sleep patterns linked to variation in health, cognition, lifestyle, and brain organization

University of Oklahoma researcher awarded funding to bridge gap between molecular data and tissue architecture

Nationally-recognized pathologist Paul N. Staats, MD, named Chair of Pathology at University of Maryland School of Medicine

The world’s snow leopards are very similar genetically. That doesn’t bode well for their future

Researchers find key to stopping deadly infection

Leafcutter ants have blind spots, just like truck drivers

Tayac receives funding for community engagement project

Parker receives funding for Elementary Education Program Professional Development School (PDS)

Physicists uncork a message in a bottle from another star

Sanders receives funding for project aimed at enabling prostheses for children with lower extremity amputation

Engineers develop solid lubricant to replace toxic materials in farming

Repurposing gemstone polishing waste to create smart cement

Patient-physician messaging by race, ethnicity, insurance type, and preferred language

Unrecognized motor difficulties and developmental coordination disorder in preschool children

[Press-News.org] Same cell death pathway involved in three forms of blindness, Penn team finds